Delivery Order SPE2DB22D9206-SPE2DB23FV5FB

Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $34,490.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from July 14-17, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
The Defense Logistics Agency awarded a $12,934.05 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from July 24-25, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-four thousand four hundred ninety dollars and eighty cents ($34,490.80) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois, and the period of performance is one day from June 29, 2023 to June 30, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand seventeen dollars and fifty-four cents ($25,017.54) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) tablets of XTANDI 40 MG for prostate cancer treatment. The single order is for product delivery to a facility in Park Ridge, Illinois by June 23, 2023 with performance beginning on June 22, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand nine hundred thirty-four dollars and five cents ($12,934.05) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois and the period of performance is September 7-8, 2023. No set aside designation or subcontractors are indicated. This order is likely placed against DLA's...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Inc. The order is for one hundred twenty (120) capsules of the prostate cancer drug XTANDI at forty (40) milligrams per capsule. Performance will take place at the prime contractor's facility located at Park Ridge, Illinois from August 22,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI, an androgen receptor inhibitor used to treat prostate cancer. Performance will take place in Park Ridge, Illinois under a one-day period from July 18 to July 19, 2023. The order was placed utilizing an existing DLA pharmaceuticals contract vehicle to...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand nine hundred twenty-nine dollars to DMS Pharmaceutical Group Inc. to supply one hundred twenty capsules of XTANDI, a forty milligram prostate cancer medication. The single order is for product delivery to a facility in Park Ridge, Illinois, with performance required between August 30th and 31st, 2022. No additional details were provided regarding the prime contractor, major subcontractors, or...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of the pharmaceutical product XTANDI 40 MG to be delivered to a facility located in Park Ridge, Illinois by July 31, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports...
The Defense Logistics Agency, on behalf of the Department of Defense, awarded a firm fixed price delivery order valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to DMS Pharmaceutical Group Inc. The order is for one hundred twenty (120) capsules of XTANDI 40 MG to be delivered to a location in Park Ridge, Illinois by June 23, 2023 in support of the Agency's medical supply needs. No set aside designation or subcontracting details were provided. The...
  • SPE2DB22D9206
    Indefinite Delivery Contract
  • SPE2DB22D9206-SPE2DB23FV5FB
    Delivery Order

The Defense Logistics Agency awarded a $17,245.40 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from September 1st through September 5th, 2023. No set aside designation or subcontractors were identified. This order supports DLA's mission to provide medical supplies and medications to military treatment facilities worldwide.

Generated 12/22/23, 2:11 PM